Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Downgraded by Zacks Investment Research
Zacks Investment Research downgraded shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) from a buy rating to a hold rating in a research note released on Tuesday morning.
According to Zacks, “Acadia Healthcare’s second-quarter 2017 earnings surpassed the Zacks Consensus Estimate, mainly driven by an increase in same facility revenue, patient days and revenue per patient day. The company is well positioned for long-term growth on the back of its inorganic strategies. Its latest Priory acquisition has substantially enhanced its asset base, making it the largest independent provider of mental health services in the U.K. Its mixed product portfolio has helped in intensifying business risk. The company’s strong balance sheet, with increasing cash flow is another positive. Year to date, shares of Acadia Healthcare have outperformed the industry. But the company suffers from high debt, escalating interest expenses and foreign exchange fluctuation. Substantial integration risks associated with its frequent acquisitions are major headwinds.”
A number of other research firms have also recently weighed in on ACHC. Deutsche Bank AG lifted their price objective on Acadia Healthcare from $58.00 to $60.00 and gave the company a buy rating in a research report on Monday. UBS AG reaffirmed a positive rating and set a $60.00 price objective (up from $54.00) on shares of Acadia Healthcare in a research report on Monday. Craig Hallum reaffirmed a buy rating and set a $65.00 price objective (up from $52.00) on shares of Acadia Healthcare in a research report on Monday. BidaskClub cut Acadia Healthcare from a buy rating to a hold rating in a research report on Monday. Finally, Mizuho lifted their price objective on Acadia Healthcare from $57.00 to $60.00 and gave the company a buy rating in a research report on Friday, July 28th. Five investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average target price of $59.21.
Shares of Acadia Healthcare (NASDAQ ACHC) traded up 0.63% during midday trading on Tuesday, hitting $52.90. The stock had a trading volume of 88,870 shares. The firm has a market cap of $4.65 billion, a price-to-earnings ratio of 581.32 and a beta of 1.15. Acadia Healthcare has a 12 month low of $32.54 and a 12 month high of $54.73. The stock’s 50 day moving average price is $48.90 and its 200 day moving average price is $44.01.
Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The firm had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. During the same period in the previous year, the firm earned $0.73 EPS. The business’s quarterly revenue was down 5.4% on a year-over-year basis. On average, equities analysts forecast that Acadia Healthcare will post $2.45 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This piece of content was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of United States & international copyright and trademark laws. The legal version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/04/acadia-healthcare-company-inc-nasdaqachc-downgraded-by-zacks-investment-research.html.
In related news, Director Reeve B. Waud sold 1,240,000 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $51.72, for a total value of $64,132,800.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Scott Schwieger sold 2,891 shares of the business’s stock in a transaction that occurred on Monday, July 31st. The stock was sold at an average price of $52.85, for a total value of $152,789.35. Following the completion of the transaction, the insider now directly owns 8,841 shares in the company, valued at $467,246.85. The disclosure for this sale can be found here. Over the last three months, insiders sold 2,119,585 shares of company stock worth $104,503,747. 11.10% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. BlackRock Inc. boosted its position in Acadia Healthcare by 27,497.3% in the first quarter. BlackRock Inc. now owns 5,145,786 shares of the company’s stock worth $224,356,000 after buying an additional 5,127,140 shares in the last quarter. Aristotle Capital Management LLC acquired a new position in Acadia Healthcare during the first quarter worth approximately $140,071,000. FMR LLC boosted its position in Acadia Healthcare by 173.2% in the first quarter. FMR LLC now owns 2,195,002 shares of the company’s stock worth $95,702,000 after buying an additional 1,391,552 shares in the last quarter. Frontier Capital Management Co. LLC boosted its position in Acadia Healthcare by 112.2% in the first quarter. Frontier Capital Management Co. LLC now owns 2,087,088 shares of the company’s stock worth $90,997,000 after buying an additional 1,103,446 shares in the last quarter. Finally, Point72 Asset Management L.P. boosted its position in Acadia Healthcare by 143.4% in the first quarter. Point72 Asset Management L.P. now owns 1,085,000 shares of the company’s stock worth $47,306,000 after buying an additional 639,300 shares in the last quarter.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.